NCT06032988View on ClinicalTrials.gov

Effect of Probiotic Supplements on Metabolic Control of People With Type 2 Diabetes Mellitus in Greece

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

August 23, 2023

Primary Completion Date

September 2, 2023

Study Completion Date

September 2, 2023

Conditions
Diabetes Mellitus, Type 2
Interventions
DIETARY_SUPPLEMENT

LactoLevure

Participants will receive LactoLevure\^R probiotic dietary supplement or matching placebo once a day.

Trial Locations (1)

11526

Laiko General Hospital, Athens

All Listed Sponsors
collaborator

Uni-Pharma

INDUSTRY

lead

Konstantinos Makrilakis, MD

OTHER

NCT06032988 - Effect of Probiotic Supplements on Metabolic Control of People With Type 2 Diabetes Mellitus in Greece | Biotech Hunter | Biotech Hunter